Erik Nordkamp joins PA Consulting’s Health and Life…

PA Consulting (PA), the innovation and transformation consultancy, has welcomed Erik Nordkamp as a partner in its Health and Life Sciences team. Erik will work with pharmaceutical companies to shape growth plans, strengthen operations, and turn bold ideas into practical solutions that benefit patients.

He will also help clients harness digital and AI technologies, expand into new markets, and improve patient reach – with the overall goal of accelerating the delivery of life-changing treatments.

Erik has over 25 years of experience in senior roles at major pharmaceutical companies, where he has led teams in strategy, business change, and operations, including CEO of General Medicines at Arcera, Chief Commercial Officer at Mundipharma, Managing Director at Pfizer UK and Senior Director Transformation & Lean Six Sigma at Eli Lilly. In addition to this, he led the led the ABPI as its President during the Brexit negotiations and was a Non-executive Director for Kings College London Trust.

I’m pleased to join PA Consulting’s leading Health and Life Sciences team. The industry faces rapid transformation - from digital innovation to evolving patient expectations - and PA is perfectly placed to help clients navigate these challenges and seize new opportunities. I look forward to working with clients and the team to shape new strategies and use technology in ways that make a real difference for patients.”

Erik Nordkamp PA health and life sciences expert

We’re thrilled to have Erik on board. His extensive experience and leadership in the pharmaceutical sector will be a real asset as we help clients navigate change, seize new opportunities, and deliver better outcomes for patients. Erik’s insight will further strengthen our ability to drive innovation and support clients across the life sciences landscape.”

Simon Collier Global Head of Healthcare and Life Sciences at PA

Erik’s appointment will enhance PA’s capabilities in growth strategy, organisational effectiveness, and digital transformation – supporting pharmaceutical clients to navigate global expansion, build innovative go-to-market models, and accelerate the adoption of digital and AI technologies.